DEA’s Potentially Stifled Research: Echoes of Dr. Craker’s Struggles in Today’s Cannabis Scientific Landscape
The Drug Enforcement Administration (DEA) is once again facing accusations of creating significant barriers for cannabis research, a pattern that mirrors the formidable challenges encountered by the late Dr. Lyle Craker. His persistent efforts to advance scientific understanding and patient access to cannabis-based medicines were significantly hampered by what many perceived as bureaucratic obstruction. Now,…

